347 related articles for article (PubMed ID: 11418480)
21. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
Fisher GH; Rosenberg FJ; Straus SE; Dale JK; Middleton LA; Lin AY; Strober W; Lenardo MJ; Puck JM
Cell; 1995 Jun; 81(6):935-46. PubMed ID: 7540117
[TBL] [Abstract][Full Text] [Related]
22. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
23. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
24. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
Maric I; Pittaluga S; Dale JK; Niemela JE; Delsol G; Diment J; Rosai J; Raffeld M; Puck JM; Straus SE; Jaffe ES
Am J Surg Pathol; 2005 Jul; 29(7):903-11. PubMed ID: 15958855
[TBL] [Abstract][Full Text] [Related]
25. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
Dianzani U; Bragardo M; DiFranco D; Alliaudi C; Scagni P; Buonfiglio D; Redoglia V; Bonissoni S; Correra A; Dianzani I; Ramenghi U
Blood; 1997 Apr; 89(8):2871-9. PubMed ID: 9108407
[TBL] [Abstract][Full Text] [Related]
27. [The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].
Beltinger C; Böhler T; Schrappe M; Ludwig WD; Debatin KM
Klin Padiatr; 1998; 210(4):153-8. PubMed ID: 9743945
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune lymphoproliferative syndrome presenting with glomerulonephritis.
Kanegane H; Vilela MM; Wang Y; Futatani T; Matsukura H; Miyawaki T
Pediatr Nephrol; 2003 May; 18(5):454-6. PubMed ID: 12736807
[TBL] [Abstract][Full Text] [Related]
29. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Bi LL; Pan G; Atkinson TP; Zheng L; Dale JK; Makris C; Reddy V; McDonald JM; Siegel RM; Puck JM; Lenardo MJ; Straus SE
BMC Med Genet; 2007 Jul; 8():41. PubMed ID: 17605793
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
31. Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome.
Boulanger E; Rieux-Laucat F; Picard C; Legall M; Sigaux F; Clauvel JP; Oksenhendler E; Le Deist F; Meignin V
Br J Haematol; 2001 May; 113(2):432-4. PubMed ID: 11380411
[TBL] [Abstract][Full Text] [Related]
32. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Martin DA; Zheng L; Siegel RM; Huang B; Fisher GH; Wang J; Jackson CE; Puck JM; Dale J; Straus SE; Peter ME; Krammer PH; Fesik S; Lenardo MJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4552-7. PubMed ID: 10200300
[TBL] [Abstract][Full Text] [Related]
33. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
Drappa J; Vaishnaw AK; Sullivan KE; Chu JL; Elkon KB
N Engl J Med; 1996 Nov; 335(22):1643-9. PubMed ID: 8929361
[TBL] [Abstract][Full Text] [Related]
34. [The autoimmune lymphoproliferative syndrome: a disorder of programmed cell death].
Seegers D; Peña AS; Bouma G
Ned Tijdschr Geneeskd; 2004 Feb; 148(8):371-6. PubMed ID: 15032090
[TBL] [Abstract][Full Text] [Related]
35. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
[TBL] [Abstract][Full Text] [Related]
36. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation.
Xie Y; Pittaluga S; Price S; Raffeld M; Hahn J; Jaffe ES; Rao VK; Maric I
Haematologica; 2017 Feb; 102(2):364-372. PubMed ID: 27846610
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Worth A; Thrasher AJ; Gaspar HB
Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
[TBL] [Abstract][Full Text] [Related]
39. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
40. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome.
Goldman FD; Vibhakar R; Puck JM; Straus SE; Ballas ZK; Hollenback C; Loew T; Thompson A; Song K; Cook RT
Clin Immunol; 2002 Jul; 104(1):31-9. PubMed ID: 12139945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
